Zimmer Biomet Holdings Inc (ZBH) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Zimmer Biomet Holdings Inc   (NYSE: ZBH)
 

Zimmer Biomet Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Zimmer Biomet Holdings Inc inventory turnover ratio, the Zimmer Biomet Holdings Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 1.13 in the third quarter 2026, ZBH's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Zimmer Biomet Holdings Inc in Sep 30 2026 quarter, has decreased to 323 days, compare to 332 days, in the Jun 30 2026 quarter.

Within Healthcare sector 300 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. 454.

ZBH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Zimmer Biomet Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZBH Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -4.69 % -7.49 % 0.12 % 2.29 % 4.85 %
Y / Y Cost of Sales Growth 6.29 % 7.31 % 4.8 % 35.06 % 3.84 %
Inventory Turnover Ratio (TTM) 1.13 1.1 1.06 1.05 0.97
ZBH's Total Ranking # 454 # 454 # 1258 # 1151 #
Average inventory processing period 322 331 343 346 376
Seq. Inventory Growth 4.27 % 1.05 % -1.73 % -7.94 % 1.2 %
Seq. Cost of Sales Growth -6.45 % 10.29 % -27.28 % 41.68 % -5.56 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 138
Healthcare Sector # 301
Overall Market # 454

Inventory Turnover Ratio Statistics
High Average Low
1.38 0.98 0.81
(Sep 30 2013)   (Mar 31 2011)



ZBH Company Profile >> Back to ZBH Efficiency Comparisons >> Compare ZBH Inventory Turnover Ratio to its Competitors

Financial Statements
Zimmer Biomet Holdings Inc 's Inventories $ 2,367 Millions Visit ZBH's Balance sheet
Zimmer Biomet Holdings Inc 's Cost of Revenues TTM $ 2,599 Millions Visit ZBH's Income Statement
What are ZBH's Sales? Visit ZBH's Sales by Segment

Other Inventory Turnover Ratios
Zimmer Biomet Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ZBH's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ZBH's Competitors
Inventory Turnover Ratio for ZBH's Suppliers
Inventory Turnover Ratio for ZBH's Customers

You may also want to know
ZBH's Sales Growth Rates ZBH's Pe Price to earnings ratio ZBH's Receivables Turnover Ratio ZBH's Stock Quote
ZBH's Net Income Growth Rates ZBH's Ps Price to Sales ratio ZBH's Sales per Employee ZBH's Asset Turnover Ratio
ZBH's Net Margin ZBH's Pb Price to Book ratio ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions
Illumina Inc   2.36 $ 1,458.000  Millions$ 618  Millions
Mirum Pharmaceuticals Inc   2.35 $ 59.684  Millions$ 25  Millions
Aquestive Therapeutics Inc   2.34 $ 16.928  Millions$ 7  Millions
Resmed Inc   2.33 $ 2,214.675  Millions$ 952  Millions
Beta Bionics Inc   2.31 $ 53.285  Millions$ 23  Millions
Merit Medical Systems Inc  2.25 $ 817.001  Millions$ 363  Millions
Bioventus Inc   2.24 $ 183.856  Millions$ 82  Millions
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions
Standard Biotools Inc   2.16 $ 39.539  Millions$ 18  Millions
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Boston Scientific Corporation  2.06 $ 6,502.000  Millions$ 3,153  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions

Date modified: 2026-11-05T09:52:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.